Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2024. Start Trial.
Date Value
October 08, 2026 8.718
October 07, 2026 8.669
October 06, 2026 8.497
October 05, 2026 8.773
October 02, 2026 8.793
October 01, 2026 8.811
September 30, 2026 9.156
September 29, 2026 9.227
September 28, 2026 9.282
September 25, 2026 9.171
September 24, 2026 9.696
September 23, 2026 9.928
September 22, 2026 10.50
September 21, 2026 10.18
September 18, 2026 9.994
September 17, 2026 10.24
September 16, 2026 10.05
September 15, 2026 10.04
September 14, 2026 10.07
September 11, 2026 9.966
September 10, 2026 9.983
September 09, 2026 10.05
September 08, 2026 10.11
September 04, 2026 10.44
September 03, 2026 10.32
Date Value
September 02, 2026 10.15
September 01, 2026 9.994
August 31, 2026 10.13
August 28, 2026 9.955
August 27, 2026 9.979
August 26, 2026 10.24
August 25, 2026 9.840
August 24, 2026 9.675
August 21, 2026 9.429
August 20, 2026 9.464
August 19, 2026 9.954
August 18, 2026 9.985
August 17, 2026 10.19
August 14, 2026 10.36
August 13, 2026 10.39
August 12, 2026 10.29
August 11, 2026 10.24
August 10, 2026 10.10
August 07, 2026 10.47
August 06, 2026 10.28
August 05, 2026 10.28
August 04, 2026 10.09
August 03, 2026 9.345
July 31, 2026 9.230
July 30, 2026 9.970

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Agenus, Inc. --
Amgen, Inc. 19.19
BioCryst Pharmaceuticals, Inc. --
Imunon, Inc. 1.203
Curis, Inc. 0.2768

Price to Book Value Related Metrics

Price 138.96
Earnings Yield -3.48%
Market Cap 2.000B